Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03UHT
|
||||
Former ID |
DNC007680
|
||||
Drug Name |
MCL-458
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528787] | ||
Structure |
Download2D MOL |
||||
Formula |
C22H28N2O2
|
||||
Canonical SMILES |
C1CCC23CCN(C(C2C1)CC4=CC5=C(C=C34)OC(=O)N5)CC6CCC6
|
||||
InChI |
1S/C22H28N2O2/c25-21-23-18-10-15-11-19-16-6-1-2-7-22(16,17(15)12-20(18)26-21)8-9-24(19)13-14-4-3-5-14/h10,12,14,16,19H,1-9,11,13H2,(H,23,25)/t16-,19+,22+/m0/s1
|
||||
InChIKey |
PSLNEDDFOIXXGT-DKZVUGQWSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Kappa-type opioid receptor | Target Info | Inhibitor | [528787] | |
Delta-type opioid receptor | Target Info | Inhibitor | [528787] | ||
Mu-type opioid receptor | Target Info | Inhibitor | [528787] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Opioid prodynorphin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Enkephalin release | |||||
Opioid proenkephalin pathway | |||||
Opioid proopiomelanocortin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.